JOHN T HENDERSON Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JOHN T HENDERSON.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JOHN T HENDERSON. JOHN T HENDERSON is Director in MYRIAD GENETICS INC ($MYGN) and Director in INVERESK RESEARCH GROUP INC ($IRGI) and Director in CYTOKINETICS INC ($CYTK).
Latest Insider Trading Transactions of JOHN T HENDERSON
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CYTK, IRGI, MYGN
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 13 2021 | CYTK | CYTOKINETICS INC | HENDERSON JOHN T | Director | Option Exercise | A | 24.32 | 10,000 | 243,200 | 10,000 | |
May 13 2021 | CYTK | CYTOKINETICS INC | HENDERSON JOHN T | Director | Grant | A | 0.00 | 5,000 | 0 | 12,410 | 7.4 K to 12.4 K (+67.48 %) |
Apr 05 2021 | CYTK | CYTOKINETICS INC | HENDERSON JOHN T | Director | Option Exercise | M | 8.64 | 1,100 | 9,504 | 0 | |
Apr 05 2021 | CYTK | CYTOKINETICS INC | HENDERSON JOHN T | Director | Option Exercise | M | 8.64 | 1,100 | 9,504 | 1,100 | |
Apr 05 2021 | CYTK | CYTOKINETICS INC | HENDERSON JOHN T | Director | Option Exercise | M | 8.64 | 1,133 | 9,789 | 2,200 | |
Apr 05 2021 | CYTK | CYTOKINETICS INC | HENDERSON JOHN T | Director | Sell | S | 23.31 | 1,100 | 25,641 | 7,410 | 8.5 K to 7.4 K (-12.93 %) |
Apr 05 2021 | CYTK | CYTOKINETICS INC | HENDERSON JOHN T | Director | Buy | M | 8.64 | 1,100 | 9,504 | 8,510 | 7.4 K to 8.5 K (+14.84 %) |
Apr 05 2021 | CYTK | CYTOKINETICS INC | HENDERSON JOHN T | Director | Sell | S | 23.31 | 1,100 | 25,641 | 7,410 | 8.5 K to 7.4 K (-12.93 %) |
Apr 05 2021 | CYTK | CYTOKINETICS INC | HENDERSON JOHN T | Director | Buy | M | 8.64 | 1,100 | 9,504 | 8,510 | 7.4 K to 8.5 K (+14.84 %) |
Apr 05 2021 | CYTK | CYTOKINETICS INC | HENDERSON JOHN T | Director | Sell | S | 24.00 | 1,133 | 27,192 | 7,410 | 8.5 K to 7.4 K (-13.26 %) |
Apr 05 2021 | CYTK | CYTOKINETICS INC | HENDERSON JOHN T | Director | Buy | M | 8.64 | 1,133 | 9,789 | 8,543 | 7.4 K to 8.5 K (+15.29 %) |
Dec 31 2020 | CYTK | CYTOKINETICS INC | HENDERSON JOHN T | Director | Option Exercise | M | 12.96 | 858 | 11,120 | 0 | |
Dec 31 2020 | CYTK | CYTOKINETICS INC | HENDERSON JOHN T | Director | Sell | S | 20.31 | 858 | 17,426 | 899 | 1.8 K to 899 (-48.83 %) |
Dec 31 2020 | CYTK | CYTOKINETICS INC | HENDERSON JOHN T | Director | Buy | M | 12.96 | 858 | 11,120 | 1,757 | 899 to 1.8 K (+95.44 %) |
Oct 05 2020 | CYTK | CYTOKINETICS INC | HENDERSON JOHN T | Director | Option Exercise | M | 12.96 | 1,500 | 19,440 | 858 | |
Oct 05 2020 | CYTK | CYTOKINETICS INC | HENDERSON JOHN T | Director | Option Exercise | M | 12.96 | 1,500 | 19,440 | 2,358 | |
Oct 05 2020 | CYTK | CYTOKINETICS INC | HENDERSON JOHN T | Director | Sell | S | 28.00 | 1,500 | 42,000 | 899 | 2.4 K to 899 (-62.53 %) |
Oct 05 2020 | CYTK | CYTOKINETICS INC | HENDERSON JOHN T | Director | Buy | M | 12.96 | 1,500 | 19,440 | 2,399 | 899 to 2.4 K (+166.85 %) |
Oct 05 2020 | CYTK | CYTOKINETICS INC | HENDERSON JOHN T | Director | Sell | S | 30.00 | 1,500 | 45,000 | 899 | 2.4 K to 899 (-62.53 %) |
Oct 05 2020 | CYTK | CYTOKINETICS INC | HENDERSON JOHN T | Director | Buy | M | 12.96 | 1,500 | 19,440 | 2,399 | 899 to 2.4 K (+166.85 %) |
May 20 2020 | CYTK | CYTOKINETICS INC | HENDERSON JOHN T | Director | Option Exercise | M | 16.86 | 3,333 | 56,194 | 0 | |
May 20 2020 | CYTK | CYTOKINETICS INC | HENDERSON JOHN T | Director | Payment of Exercise | F | 20.93 | 2,684 | 56,176 | 899 | 3.6 K to 899 (-74.91 %) |
May 20 2020 | CYTK | CYTOKINETICS INC | HENDERSON JOHN T | Director | Buy | M | 16.86 | 3,333 | 56,194 | 3,583 | 250 to 3.6 K (+1,333.20 %) |
May 14 2020 | CYTK | CYTOKINETICS INC | HENDERSON JOHN T | Director | Option Exercise | A | 21.61 | 20,000 | 432,200 | 20,000 | |
Feb 14 2020 | CYTK | CYTOKINETICS INC | HENDERSON JOHN T | Director | Option Exercise | A | 15.43 | 6,415 | 98,983 | 6,415 | |
Jan 06 2020 | CYTK | CYTOKINETICS INC | HENDERSON JOHN T | Director | Option Exercise | A | 10.55 | 1,517 | 16,004 | 1,517 | |
Jan 02 2020 | CYTK | CYTOKINETICS INC | HENDERSON JOHN T | Director | Buy | P | 8.57 | 6,000 | 51,427 | 6,250 | 250 to 6.3 K (+2,400.00 %) |
Dec 06 2019 | MYGN | MYRIAD GENETICS IN ... | HENDERSON JOHN T | Director | Grant | A | 0.00 | 11,687 | 0 | 76,040 | 64.4 K to 76 K (+18.16 %) |
Nov 20 2019 | CYTK | CYTOKINETICS INC | HENDERSON JOHN T | Director | Option Exercise | A | 10.68 | 20,000 | 213,600 | 20,000 | |
Nov 07 2019 | MYGN | MYRIAD GENETICS IN ... | HENDERSON JOHN T | Director | Buy | P | 23.46 | 1,750 | 41,056 | 2,050 | 300 to 2.1 K (+583.33 %) |
Nov 07 2019 | MYGN | MYRIAD GENETICS IN ... | HENDERSON JOHN T | Director | Buy | P | 23.46 | 5,250 | 123,167 | 64,353 | 59.1 K to 64.4 K (+8.88 %) |
May 17 2019 | CYTK | CYTOKINETICS INC | HENDERSON JOHN T | Director | Option Exercise | A | 10.68 | 20,000 | 213,600 | 20,000 | |
Jan 04 2019 | CYTK | CYTOKINETICS INC | HENDERSON JOHN T | Director | Option Exercise | A | 6.82 | 8,247 | 56,245 | 8,247 | |
Nov 30 2018 | MYGN | MYRIAD GENETICS IN ... | HENDERSON JOHN T | Director | Grant | A | 0.00 | 9,360 | 0 | 59,103 | 49.7 K to 59.1 K (+18.82 %) |
Jul 13 2018 | MYGN | MYRIAD GENETICS IN ... | HENDERSON JOHN T | Director | Option Exercise | M | 24.39 | 10,000 | 243,900 | 0 | |
Jul 13 2018 | MYGN | MYRIAD GENETICS IN ... | HENDERSON JOHN T | Director | Option Exercise | M | 24.39 | 10,000 | 243,900 | 10,000 | |
Jul 13 2018 | MYGN | MYRIAD GENETICS IN ... | HENDERSON JOHN T | Director | Option Exercise | M | 24.39 | 10,000 | 243,900 | 20,000 | |
Jul 13 2018 | MYGN | MYRIAD GENETICS IN ... | HENDERSON JOHN T | Director | Sell | S | 40.17 | 10,000 | 401,700 | 49,743 | 59.7 K to 49.7 K (-16.74 %) |
Jul 13 2018 | MYGN | MYRIAD GENETICS IN ... | HENDERSON JOHN T | Director | Buy | M | 24.39 | 10,000 | 243,900 | 59,743 | 49.7 K to 59.7 K (+20.10 %) |
Jul 13 2018 | MYGN | MYRIAD GENETICS IN ... | HENDERSON JOHN T | Director | Sell | S | 42.01 | 10,000 | 420,085 | 49,743 | 59.7 K to 49.7 K (-16.74 %) |
Jul 13 2018 | MYGN | MYRIAD GENETICS IN ... | HENDERSON JOHN T | Director | Buy | M | 24.39 | 10,000 | 243,900 | 59,743 | 49.7 K to 59.7 K (+20.10 %) |
Jul 13 2018 | MYGN | MYRIAD GENETICS IN ... | HENDERSON JOHN T | Director | Sell | S | 44.00 | 10,000 | 440,000 | 49,743 | 59.7 K to 49.7 K (-16.74 %) |
Jul 13 2018 | MYGN | MYRIAD GENETICS IN ... | HENDERSON JOHN T | Director | Buy | M | 24.39 | 10,000 | 243,900 | 59,743 | 49.7 K to 59.7 K (+20.10 %) |
May 17 2018 | CYTK | CYTOKINETICS INC | HENDERSON JOHN T | Director | Option Exercise | A | 9.45 | 20,000 | 189,000 | 20,000 | |
Jan 04 2018 | CYTK | CYTOKINETICS INC | HENDERSON JOHN T | Director | Option Exercise | A | 8.75 | 11,428 | 99,995 | 11,428 | |
Nov 30 2017 | MYGN | MYRIAD GENETICS IN ... | HENDERSON JOHN T | Director | Grant | A | 0.00 | 7,219 | 0 | 49,743 | 42.5 K to 49.7 K (+16.98 %) |
Sep 05 2017 | MYGN | MYRIAD GENETICS IN ... | HENDERSON JOHN T | Director | Option Exercise | M | 16.46 | 10,000 | 164,600 | 0 | |
Sep 05 2017 | MYGN | MYRIAD GENETICS IN ... | HENDERSON JOHN T | Director | Option Exercise | M | 16.46 | 10,000 | 164,600 | 10,000 | |
Sep 05 2017 | MYGN | MYRIAD GENETICS IN ... | HENDERSON JOHN T | Director | Option Exercise | M | 16.46 | 10,000 | 164,600 | 20,000 | |
Sep 05 2017 | MYGN | MYRIAD GENETICS IN ... | HENDERSON JOHN T | Director | Sell | S | 30.30 | 10,000 | 302,981 | 42,524 | 52.5 K to 42.5 K (-19.04 %) |
Sep 05 2017 | MYGN | MYRIAD GENETICS IN ... | HENDERSON JOHN T | Director | Buy | M | 16.46 | 10,000 | 164,600 | 52,524 | 42.5 K to 52.5 K (+23.52 %) |
Sep 05 2017 | MYGN | MYRIAD GENETICS IN ... | HENDERSON JOHN T | Director | Sell | S | 30.30 | 10,000 | 303,003 | 42,524 | 52.5 K to 42.5 K (-19.04 %) |
Sep 05 2017 | MYGN | MYRIAD GENETICS IN ... | HENDERSON JOHN T | Director | Buy | M | 16.46 | 10,000 | 164,600 | 52,524 | 42.5 K to 52.5 K (+23.52 %) |
Sep 05 2017 | MYGN | MYRIAD GENETICS IN ... | HENDERSON JOHN T | Director | Sell | S | 30.31 | 10,000 | 303,056 | 42,524 | 52.5 K to 42.5 K (-19.04 %) |
Sep 05 2017 | MYGN | MYRIAD GENETICS IN ... | HENDERSON JOHN T | Director | Buy | M | 16.46 | 10,000 | 164,600 | 52,524 | 42.5 K to 52.5 K (+23.52 %) |
May 22 2017 | CYTK | CYTOKINETICS INC | HENDERSON JOHN T | Director | Option Exercise | A | 14.25 | 20,000 | 285,000 | 20,000 | |
Feb 23 2017 | MYGN | MYRIAD GENETICS IN ... | HENDERSON JOHN T | Director | Buy | P | 18.57 | 400 | 7,429 | 42,524 | 42.1 K to 42.5 K (+0.95 %) |
Feb 23 2017 | MYGN | MYRIAD GENETICS IN ... | HENDERSON JOHN T | Director | Buy | P | 18.58 | 3,600 | 66,888 | 42,124 | 38.5 K to 42.1 K (+9.34 %) |
Feb 23 2017 | MYGN | MYRIAD GENETICS IN ... | HENDERSON JOHN T | Director | Buy | P | 18.81 | 2,000 | 37,613 | 38,524 | 36.5 K to 38.5 K (+5.48 %) |
Jan 04 2017 | CYTK | CYTOKINETICS INC | HENDERSON JOHN T | Director | Option Exercise | A | 12.40 | 8,064 | 99,994 | 8,064 | |
Dec 01 2016 | MYGN | MYRIAD GENETICS IN ... | HENDERSON JOHN T | Director | Grant | A | 0.00 | 15,024 | 0 | 36,524 | 21.5 K to 36.5 K (+69.88 %) |
Sep 13 2016 | MYGN | MYRIAD GENETICS IN ... | HENDERSON JOHN T | Director | Option Exercise | M | 10.60 | 2,007 | 21,274 | 0 | |
Sep 13 2016 | MYGN | MYRIAD GENETICS IN ... | HENDERSON JOHN T | Director | Option Exercise | M | 10.60 | 27,993 | 296,726 | 2,007 | |
Sep 13 2016 | MYGN | MYRIAD GENETICS IN ... | HENDERSON JOHN T | Director | Sell | S | 20.21 | 2,007 | 40,568 | 21,500 | 23.5 K to 21.5 K (-8.54 %) |
Sep 13 2016 | MYGN | MYRIAD GENETICS IN ... | HENDERSON JOHN T | Director | Buy | M | 10.60 | 2,007 | 21,274 | 23,507 | 21.5 K to 23.5 K (+9.33 %) |
Sep 13 2016 | MYGN | MYRIAD GENETICS IN ... | HENDERSON JOHN T | Director | Sell | S | 20.51 | 27,993 | 574,248 | 21,500 | 49.5 K to 21.5 K (-56.56 %) |
Sep 13 2016 | MYGN | MYRIAD GENETICS IN ... | HENDERSON JOHN T | Director | Buy | M | 10.60 | 27,993 | 296,726 | 49,493 | 21.5 K to 49.5 K (+130.20 %) |
May 20 2016 | CYTK | CYTOKINETICS INC | HENDERSON JOHN T | Director | Option Exercise | A | 7.61 | 20,000 | 152,200 | 20,000 | |
Jan 06 2016 | CYTK | CYTOKINETICS INC | HENDERSON JOHN T | Director | Option Exercise | A | 10.00 | 8,750 | 87,500 | 8,750 | |
Dec 07 2015 | MYGN | MYRIAD GENETICS IN ... | HENDERSON JOHN T | Director | Grant | A | 0.00 | 7,500 | 0 | 21,500 | 14 K to 21.5 K (+53.57 %) |
May 21 2015 | CYTK | CYTOKINETICS INC | HENDERSON JOHN T | Director | Option Exercise | A | 6.21 | 20,000 | 124,200 | 20,000 | |
Oct 22 2004 | IRGI | INVERESK RESEARCH ... | HENDERSON JOHN T | Director | Option Exercise | D | 13.00 | 7,500 | 97,500 | 0 | |
Oct 22 2004 | IRGI | INVERESK RESEARCH ... | HENDERSON JOHN T | Director | Option Exercise | D | 15.00 | 5,000 | 75,000 | 0 | |
Oct 22 2004 | IRGI | INVERESK RESEARCH ... | HENDERSON JOHN T | Director | Option Exercise | D | 30.00 | 5,000 | 150,000 | 0 | |
Oct 22 2004 | IRGI | INVERESK RESEARCH ... | HENDERSON JOHN T | Director | Sell | D | 0.00 | 1,000 | 0 | 0 | 1,000 to 0 (-100.00 %) |
May 06 2004 | IRGI | INVERESK RESEARCH ... | HENDERSON JOHN T | Director | Option Exercise | A | 30.00 | 5,000 | 150,000 | 5,000 | |
Mar 19 2004 | IRGI | INVERESK RESEARCH ... | HENDERSON JOHN T | Director | Option Exercise | A | 17.75 | 5,000 | 88,750 | 5,000 |
Page: 1